You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 4, April 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 11TH ANNUAL SURGICAL SYMPOSIUM OF THE ASSOCIATION OF VETERANS ADMINISTRATION SURGEONS, PORTLAND, ORE, MAY 6-9, 1987
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Splenectomy and the Induction of Murine Colon Cancer

Christine C. Hull, MD; Pam Galloway, MD; Nahida Gordon, PhD; Stanton L. Gerson, MD; Natalie Hawkins; Thomas A. Stellato, MD

Arch Surg. 1988;123(4):462-464.


Abstract

• The Influence of a functional spleen on Induction and growth of cancer is unknown. Both beneficial and detrimental results have been observed in tumor-bearing hosts following splenectomy. We examined the effect of splenectomy, splenic autotransplantation, and splenic preservation on the induction and growth of 1,2-dimethylhydrazine (DMH)—induced murine colon cancer. Following splenectomy there was a significant increase in malignant tumors but no increase in benign tumors. To rule out the possibility that splenectomy increased the carcinogenicity of DMH by decreasing the capacity for DNA repair in colon cells, the units of 06-alkylguanine DNA alkyltransferase were measured in tumor-free and malignant colon tissue from both splenectomized and control rats. This repair protein was chosen because it is known to protect cells from the mutagenic effects of methylating agents. There was no significant difference in the alkyltransferase activity of tumor-free colon vs malignant tumor or between treatment regimens. Thus, the ability of the spleen to protect rats from the induction of malignant colon tumors induced by DMH is most likely due to preservation of immunologic surveillance in the host.

(Arch Surg 1988;123:462-464)



Author Affiliations

From the Departments of Surgery (Drs Hull, Stellato, and Gordon and Ms Hawkins), Epidemiology and Biostatistics (Dr Gordon), Pathology (Dr Galloway), and Medicine (Dr Gerson), Case Western Reserve University School of Medicine, and the Ireland Cancer Center (Drs Stellato, Gordon, Gerson), Cleveland.


Footnotes

Accepted for publication Oct 2, 1987.

Read before the Association of Veterans Administration Surgeons, Portland, Ore, May 7, 1987.

Reprint requests to University Hospitals of Cleveland, 2074 Abington Rd, Cleveland, OH 44106 (Dr Stellato).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Spleen-Dependent Turnover of CD11b Peripheral Blood B Lymphocytes in Bovine Leukemia Virus-Infected Sheep
Florins et al.
J. Virol. 2006;80:11998-12008.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.